S 3565 establishes a state-funded program to provide mental health services to New Jersey veterans through grants to qualified organizations. It appropriates $2 million from the General Fund to the Department of Veterans Affairs, which will distribute funds to veterans' organizations (including tax-exempt groups and specific entities like the New Jersey SOS Veterans Stakeholders Group) that contract with licensed mental health professionals. The bill requires grantees to provide mental health services directly to veterans, with the program taking effect immediately. This legislation directly affects veterans seeking mental health care and the eligible organizations administering the services.
New Jersey's A 797 prohibits the sale of certain consumer products containing intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS) starting in 2026. It directly affects consumers purchasing items like feminine hygiene products, juvenile products (e.g., baby sleepers, car seats), cookware, apparel, and cosmetics. The bill bans PFAS in these products but excludes regulated medical devices, FDA-approved food packaging, and items required by federal law. Key provisions require manufacturers to reformulate products to avoid intentionally added PFAS, with specific exemptions for items already covered by federal regulations. The bill is currently before the Assembly Consumer Affairs Committee.
This New Jersey bill (A 1793) creates a "Recovery Tax Credit Program" that provides tax incentives to employers who hire and retain individuals recovering from substance use disorders. Employers must become "certified" by meeting requirements like partnering with recovery providers and offering qualifying health insurance. Certified employers can claim tax credits up to $2,000 per eligible employee (based on hours worked, minimum 500 hours), with a total annual budget cap of $2 million. The program directly affects employers in New Jersey and individuals in recovery who meet the defined eligibility criteria.
This bill (A 3182, "Addiction Medicine Philanthropy Act") encourages physicians to provide free substance use disorder treatment by limiting their malpractice liability. Physicians who treat at least 10% of their patients for substance use disorders without compensation qualify for a $250,000 cap on non-financial damages (like pain and suffering) in related malpractice lawsuits. The State Board of Medical Examiners verifies the 10% threshold and notifies physicians and insurers, triggering the cap for the following calendar year. It directly affects physicians offering uncompensated care, aiming to reduce their malpractice insurance costs while supporting access to addiction treatment.
Bill A 2205 requires New Jersey's Commissioner of Health (working with the Attorney General) to create clear, easily understandable signs for emergency rooms. These signs must display VCCO services/benefits, contact details, and how to file a compensation claim. The bill mandates posting these signs in all general hospital emergency departments and satellite emergency departments, with electronic displays permitted. It aims to make VCCO information more accessible to individuals who may qualify for victim compensation after crimes. The bill takes effect four months after enactment.
This bill requires New Jersey counties to expand community mental health programs to include mental health services specifically for veterans and prohibits denying veterans these services based solely on their military status. It amends existing law to explicitly list "Services for veterans" as a required component of community mental health centers and mandates that state funding for mental health services must cover veterans in need. Counties must refer veterans to the VA for eligibility determination while ensuring they receive county services during the wait, and cannot deny services due to veteran status or VA wait times. The bill directly affects veterans seeking mental health care and county mental health programs receiving state funding.
This New Jersey bill requires health insurance plans and providers to ensure their networks include enough mental health providers so that every covered person can access care. It mandates that 100% of policyholders must have access to either in-person mental health services within 15 miles and 30 days of requesting care, or telehealth services within 30 days if in-person options are unavailable. Insurance plans must cover telehealth mental health services with no higher deductibles, copays, or coinsurance than in-person visits, and reimburse providers at least the Medicaid rate. The law applies to all health insurance plans, including Medicaid managed care organizations, and self-funded plans may choose to comply.
This bill requires New Jersey's Department of Banking and Insurance (DOBI) to conduct a one-time confidential review of health insurance coverage for hormone replacement therapy (HRT). The review will examine how insurers administer HRT coverage under the "New Jersey Menopause Coverage Act" and whether there has been an aggregate increase in coverage since that law took effect. DOBI will analyze data on prior authorization and step therapy decisions for HRT, as well as other insurer-collected information, and must report its findings to the Legislature within six months. This review directly affects health insurance carriers (by requiring them to provide data) and DOBI (as the reviewing agency), but does not change current coverage requirements.
This New Jersey bill (A 3117) requires all health insurance plans sold in the state - including hospital service contracts, medical service plans, individual policies, group plans, and health maintenance organizations - to cover BRCA1 and BRCA2 genetic testing at no additional cost to the patient. It directly affects individuals seeking testing for these breast cancer-related genes, as well as all health insurers operating in New Jersey. The law mandates coverage "to the same extent as for any other medical condition," meaning patients won’t face extra out-of-pocket costs for this specific testing. It applies to all plans issued or renewed in New Jersey after the bill’s effective date.
This bill amends New Jersey law to extend the deadline for enrolling newborn infants in health benefits coverage from 60 to 90 days after birth. It directly affects newborns and their parents, requiring health insurance corporations to allow enrollment within this longer timeframe. The key provision states that parents must notify the insurer and pay the required subscription amount within 90 days to maintain coverage beyond that period. The bill was withdrawn as it was already enacted into law through P.L.2025, c.194.
